MedPath

Preimplantation Genetic Testing for Aneuploidies in Patients With Recurrent Implantation Failure

Not Applicable
Recruiting
Conditions
Recurrent Implantation Failure
Registration Number
NCT03900780
Lead Sponsor
Universitaire Ziekenhuizen KU Leuven
Brief Summary

Assessing whether Preimplantation Genetic Testing for Aneuploidy (PGT-A) can increase the ongoing pregnancy rate per transferred embryo and can decrease the time to pregnancy and miscarriage rate in patients with Recurrent Implantation Failure (RIF)

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
100
Inclusion Criteria
  • Women with recurrent implantation failure (previous transfer of least 4 good quality embryos in at least 3 fresh or frozen cycles)
  • BMI < 35
  • Normal hysteroscopy
Exclusion Criteria
  • thin endometrium in previous cycles (<6mm), endometriosis ASRM score III-IV, premature ovarian failure (POF, Bologna criteria), abnormal karyotype, donor oocytes or embryos, PGT-M

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
OPRat 20 weeks gestational age

Ongoing pregnancy rate per embryo transfer

Secondary Outcome Measures
NameTimeMethod
IR2 weeks

Implantation rate per transferred embryo

Trial Locations

Locations (1)

UZ Leuven

🇧🇪

Leuven, Belgium

UZ Leuven
🇧🇪Leuven, Belgium
Myriam Welkenhuysen
Contact
+3216343544
myriam.welkenhuysen@uzleuven.be
Brecht Geysenbergh, MD
Contact
+32496125137
brecht.geysenbergh@uzleuven.be

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.